These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28489794)

  • 1. Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.
    Ma S; Zheng Y; Xiao Y; Zhou P; Tan H
    Medicine (Baltimore); 2017 May; 96(19):e6888. PubMed ID: 28489794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.
    Zhang X; Harmsen WS; Mettler TA; Kim WR; Roberts RO; Therneau TM; Roberts LR; Chaiteerakij R
    Hepatology; 2014 Dec; 60(6):2008-16. PubMed ID: 24798175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and metformin in hepatocellular carcinoma.
    Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
    World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: a systematic review and meta-analysis.
    Peppas S; Doumas S; Suvarnakar A; Chou J; Arafat A; Ahmad AI; Lewis JH
    Eur J Gastroenterol Hepatol; 2024 May; 36(5):674-682. PubMed ID: 38477839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses.
    Li H; Chen Y; Hu L; Yang W; Gao Z; Liu M; Tao H; Li J
    Eur J Med Res; 2023 Sep; 28(1):392. PubMed ID: 37773165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Metformin on Recurrence Risk and Long-Term Survival in Patients with Diabetes and Renal Cell Carcinoma.
    Xu K; Ying Y
    Altern Ther Health Med; 2024 Apr; 30(4):60-65. PubMed ID: 37883777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
    Lukito AA; Pranata R; Henrina J; Lim MA; Lawrensia S; Suastika K
    Diabetes Metab Syndr; 2020; 14(6):2177-2183. PubMed ID: 33395778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis.
    Lu MZ; Li DY; Wang XF
    Panminerva Med; 2023 Sep; 65(3):351-361. PubMed ID: 31290300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oral metformin in preventing and treating age-related macular degeneration: A meta-analysis.
    Elhalag RH; Mohamed MS; Abowafia M; Mourid MR; Mahmoud N; Abourady Y; Ghali P; Moussa MH; Shah J; Motawea KR
    Medicine (Baltimore); 2024 Jul; 103(28):e38728. PubMed ID: 38996175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship between Metformin Consumption and Cancer Risk: An Updated Umbrella Review of Systematic Reviews and Meta-Analyses.
    Najafi F; Rajati F; Sarokhani D; Bavandpour M; Moradinazar M
    Int J Prev Med; 2023; 14():90. PubMed ID: 37854987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
    Hatoum D; McGowan EM
    Biomed Res Int; 2015; 2015():548436. PubMed ID: 25866793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
    Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
    Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
    Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
    Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis.
    Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R
    BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
    Shankaraiah RC; Callegari E; Guerriero P; Rimessi A; Pinton P; Gramantieri L; Silini EM; Sabbioni S; Negrini M
    Oncogene; 2019 Nov; 38(45):7035-7045. PubMed ID: 31409896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.
    Murff HJ; Roumie CL; Greevy RA; Hackstadt AJ; McGowan LED; Hung AM; Grijalva CG; Griffin MR
    Cancer Causes Control; 2018 Sep; 29(9):823-832. PubMed ID: 30022336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances.
    Saraei P; Asadi I; Kakar MA; Moradi-Kor N
    Cancer Manag Res; 2019; 11():3295-3313. PubMed ID: 31114366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    de Oliveira S; Houseright RA; Graves AL; Golenberg N; Korte BG; Miskolci V; Huttenlocher A
    J Hepatol; 2019 Apr; 70(4):710-721. PubMed ID: 30572006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin: An Old Drug with New Applications.
    Zhou J; Massey S; Story D; Li L
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241400
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.